Laboratory Testing for Menopause Diagnosis
Menopause should be diagnosed clinically based on 12 months of amenorrhea in women with an intact uterus, without requiring laboratory testing. 1
Clinical Diagnosis is Primary
The most recent Endocrine Society guideline explicitly recommends diagnosing menopause based on clinical criteria of the menstrual cycle alone 1. This approach is supported by evidence showing that no single symptom or laboratory test is accurate enough by itself to definitively rule in or rule out perimenopause 2. Clinicians should diagnose perimenopause based on menstrual history and age without relying on laboratory test results 2.
When Laboratory Testing May Be Indicated
Laboratory testing should be reserved for specific clinical scenarios where the diagnosis cannot be established by menstrual history alone 1:
Specific Indications for Lab Testing:
- Women who have undergone hysterectomy (without bilateral oophorectomy) where menstrual history is unavailable
- Women with inadequate menstrual history to ascertain menopausal status
- Young women with suspected premature ovarian insufficiency (POI) presenting with amenorrhea
Recommended Laboratory Tests When Indicated:
When laboratory confirmation is necessary, the guideline suggests 1:
- FSH levels (replicate measures): Elevated FSH >22.3-25 mIU/mL supports menopause diagnosis
- Serum estradiol: Levels <20 pg/mL on several occasions support menopause
- These measurements should be obtained on multiple occasions to account for hormonal fluctuations
Important Caveats
Common pitfall: Ordering FSH and estradiol routinely in women with clear clinical menopause (12 months amenorrhea) is unnecessary and does not change management 1. Sex steroids, gonadotropins, inhibin B, or anti-Müllerian hormone measurements do not further inform the diagnosis in women with typical presentation 1.
Timing matters: In perimenopausal women, hormone levels fluctuate significantly, making single measurements unreliable. This is why replicate measures are emphasized when testing is performed 1.
Age consideration: The prior probability of perimenopause is directly related to age 2. A 52-year-old woman with 12 months of amenorrhea needs no laboratory confirmation, while a 38-year-old with similar symptoms warrants FSH and estradiol testing to evaluate for POI.
Clinical Assessment Provides Better Information
The following clinical features have greater diagnostic utility than laboratory tests 2:
- Hot flashes: Positive likelihood ratio 2.15-4.06
- Night sweats: Positive likelihood ratio 1.90
- Self-assessment of being in transition: Positive likelihood ratio 1.53-2.13
- Vaginal dryness: Positive likelihood ratio 1.48-3.79
These symptoms, combined with menstrual pattern changes and age, provide sufficient diagnostic information in most cases.
Special Population: Low BMI Women
In women with BMI <18.5 kg/m², 30% may have FSH levels below the diagnostic threshold (<25 mIU/ml) despite being clinically menopausal 3. This highlights the complexity of determining menopausal status through laboratory testing in this population and the potential for misclassification.